These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10721944)

  • 1. Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels.
    Kuriyama M; Uno H; Watanabe H; Yamanaka H; Saito Y; Shida K
    Jpn J Clin Oncol; 1999 Dec; 29(12):617-22. PubMed ID: 10721944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone.
    Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J
    Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PSA-related variables in improving positive ratio of biopsy of prostate cancer within serum PSA gray zone.
    Liu B; Pan TJ
    Urologia; 2014; 81(3):173-6. PubMed ID: 24557815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
    Djavan B; Zlotta AR; Remzi M; Ghawidel K; Bursa B; Hruby S; Wolfram R; Schulman CC; Marberger M
    Urology; 1999 Nov; 54(5):846-52. PubMed ID: 10565745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D; Kamil ST; Pakasi LS
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
    Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection by prostate-specific antigen-related parameters.
    Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the free to total prostate specific antigen ratio and prostate specific antigen density for detecting prostate cancer in Japanese patients.
    Maeda H; Arai Y; Okubo K; Aoki Y; Okada T; Maekawa S
    Int J Urol; 1998 Jul; 5(4):343-8. PubMed ID: 9712442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].
    Han G; Gao JP; Cao XL; Hong BF; Tang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):379-81. PubMed ID: 16638346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations].
    Kawai M; Okajima K; Kobayashi K; Moriyama M
    Hinyokika Kiyo; 2006 Feb; 52(2):113-7. PubMed ID: 16541764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
    Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.
    Benson MC; McMahon DJ; Cooner WH; Olsson CA
    World J Urol; 1993; 11(4):206-13. PubMed ID: 7508785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.
    Udeh EI; Nnabugwu II; Ozoemena FO; Ugwumba FO; Aderibigbe AS; Ohayi SR; Echetabu KN
    World J Surg Oncol; 2016 Jun; 14(1):174. PubMed ID: 27356753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].
    Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; González Galán A; Zuccarino AL; García González R; Cuesta Roca C
    Arch Esp Urol; 2002 Dec; 55(10):225-34. PubMed ID: 12611220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy.
    Taverna G; Colombo P; Seveso M; Giusti G; Piccinelli A; Benetti A; Graziotti P
    Arch Ital Urol Androl; 2006 Jun; 78(2):57-60. PubMed ID: 16929604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.